IRadimed Corporation
IRMD
$96.90
$0.640.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 83.81M | 80.51M | 77.64M | 75.15M | 73.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.81M | 80.51M | 77.64M | 75.15M | 73.24M |
| Cost of Revenue | 19.49M | 18.46M | 17.88M | 17.35M | 16.89M |
| Gross Profit | 64.32M | 62.05M | 59.75M | 57.81M | 56.35M |
| SG&A Expenses | 35.24M | 34.51M | 33.29M | 32.58M | 31.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.67M | 55.66M | 53.83M | 52.51M | 51.28M |
| Operating Income | 26.15M | 24.85M | 23.81M | 22.65M | 21.96M |
| Income Before Tax | 28.36M | 26.91M | 26.03M | 24.98M | 24.28M |
| Income Tax Expenses | 5.88M | 5.73M | 5.38M | 5.19M | 5.04M |
| Earnings from Continuing Operations | 22.48 | 21.18 | 20.66 | 19.78 | 19.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.48M | 21.18M | 20.66M | 19.78M | 19.23M |
| EBIT | 26.15M | 24.85M | 23.81M | 22.65M | 21.96M |
| EBITDA | 27.31M | 25.83M | 24.60M | 23.43M | 22.78M |
| EPS Basic | 1.77 | 1.67 | 1.63 | 1.56 | 1.52 |
| Normalized Basic EPS | 1.38 | 1.32 | 1.28 | 1.23 | 1.20 |
| EPS Diluted | 1.75 | 1.65 | 1.62 | 1.55 | 1.50 |
| Normalized Diluted EPS | 1.37 | 1.31 | 1.27 | 1.22 | 1.19 |
| Average Basic Shares Outstanding | 50.89M | 50.83M | 50.78M | 50.73M | 50.68M |
| Average Diluted Shares Outstanding | 51.40M | 51.33M | 51.25M | 51.17M | 51.10M |
| Dividend Per Share | 0.71 | 0.68 | 0.66 | 0.64 | 0.47 |
| Payout Ratio | 66.90% | 39.59% | 39.33% | 39.74% | 71.11% |